Sep 20, 2021 / 08:35PM GMT
Zhiqi He - Oppenheimer & Co. Inc. - Analyst
Hello. This is Zhiqi He at Oppenheimer. Thanks for joining us at this Oppenheimer Healthcare Summit. Next company with me is Molecular Templates, and Eric. So, Eric, the stage is yours.
Eric Poma - Molecular Templates, Inc. - CEO & Chief Scientific Officer
Thank you. Thank you for the introduction or thank you for the invitation to an excellent conference. I'm here to talk about Molecular Templates. I will make some forward-looking statements as part of this presentation.
For those of you who don't know the Company, we are developing novel therapeutics off of a -- what we believe to be a really unique platform. It's a platform with unique biology and with a unique mechanism of action. We call these molecules engineered toxin bodies, or ETBs for short.
They have the specificity of an antibody because an antibody binding domain is part of the protein therapeutic here. But they then use Shiga-like toxin A, something I'll talk about in a little bit more detail in a minute, to induce
Molecular Templates Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers